Elsevier

The Lancet

Volume 297, Issue 7695, 20 February 1971, Pages 366-369
The Lancet

ORIGINAL ARTICLES
EFFECTS OF FRUCTOSE INFUSION ON LACTATE AND URIC ACID METABOLISM

https://doi.org/10.1016/S0140-6736(71)92208-2Get rights and content

Abstract

Ten healthy volunteers received 10% intravenous fructose (0·5 g. per kg. body-weight per hour) for two hours following a one-hour control period in which physiological saline solution was infused intravenously. Blood-lactate rose significantly during fructose administration; and this change was accompanied by a fall in serum-bicarbonate and a rise in serum-glucose, which fell to hypoglycæmic concentrations an hour after infusion of fructose. Blood-uric-acid did not appreciably change; urinary urate excretion, urate clearance, and the ratio of urate to creatinine clearance increased during fructose infusion with no alteration of urinary pH. The lack of hyperuricæmia suggests that the hyperuricæmic effect of fructose previously reported is dose-related and associated only with larger than physiological concentrations of fructose infused under experimental conditions. While fructose seems to remain contraindicated in clinical settings where lactate accumulation must be avoided (diabetic ketoacidosis, hypoxia, postoperative period, and uræmia), it can be safely administered in physiological concentrations without fear of hyperuricæmia.

References (23)

  • J. Perheentupa et al.

    Lancet

    (1967)
  • N.J. Hochella et al.

    Analyt. Biochem.

    (1965)
  • R.H. Herman et al.

    Am. J. clin. Nutr.

    (1968)
  • P.W. Curreri et al.

    Lancet

    (1970)
  • J. Bergstrom et al.

    Acta med. scand.

    (1968)
  • P.H. Maenpaa et al.

    Science

    (1968)
  • J. Padova et al.

    New Engl. J. Med.

    (1962)
  • W.G. Lennox

    J. Am. med. Ass.

    (1924)
  • C.S. Lieber et al.

    J. clin. Invest.

    (1962)
  • M. Miller et al.

    J. clin. Invest.

    (1952)
  • W.R. Drucker et al.

    Surg. Forum

    (1952)
  • Cited by (72)

    • Uric Acid and Chronic Kidney Disease: Still More to Do

      2023, Kidney International Reports
      Citation Excerpt :

      Dietary mechanisms may also be operative. Fructose, for example, also blocks adenosine triphosphate-binding cassette subfamily G member 2 in the intestine, reducing intestinal uric acid excretion,72 while increasing urinary excretion,73 reducing urinary pH,74 and reducing urine volume.75 Dietary intake of high purine foods can also cause transient uricosuria19 that might be important in mediating kidney injury.

    • Intestinal Hyperuricemia as a Driving Mechanism for CKD

      2023, American Journal of Kidney Diseases
    • Oral sucrose for heel lance increases adenosine triphosphate use and oxidative stress in preterm neonates

      2013, Journal of Pediatrics
      Citation Excerpt :

      As inorganic phosphate concentration decreases, oxidative phosphorylation is inhibited, reducing ATP synthesis and rapidly depleting ATP.4,6,30,31 ATP and ADP catabolism results in increased concentration of purines such as uric acid (Figure 4, E).5,6,35 These observations have been documented in adult animals as well as in children ages 11 months to 12 years5 and in healthy adults.5,6

    • Another feature of TURP syndrome: Hyperglycaemia and lactic acidosis caused by massive absorption of sorbitol

      2001, British Journal of Anaesthesia
      Citation Excerpt :

      Sorbitol and fructose are among the numerous causes of type B lactic acidosis. For instance, fructose was abandoned for parenteral nutrition several years ago because of associated metabolic disturbances similar to those encountered in this case.9 10 Furthermore, Buijs and van Zuilen have reported a time course of blood glucose, lactate and acid–base disturbances remarkably similar to this case in a patient who received 250 ml of 30% sorbitol (7.5 g) for brain volume reduction.11

    View all citing articles on Scopus
    1

    Present address: Veterans Administration Hospital, Washington, D.C.

    View full text